Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Accumulated Expenses (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Accumulated Expenses for 6 consecutive years, with $23.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 18.62% year-over-year to $23.9 million, compared with a TTM value of $23.9 million through Dec 2025, up 18.62%, and an annual FY2025 reading of $23.9 million, up 18.62% over the prior year.
  • Accumulated Expenses was $23.9 million for Q4 2025 at Viemed Healthcare, down from $25.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $25.0 million in Q3 2025 and bottomed at $8.7 million in Q1 2022.
  • Average Accumulated Expenses over 5 years is $14.9 million, with a median of $14.8 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses plummeted 35.54% in 2021, then skyrocketed 75.05% in 2023.
  • Year by year, Accumulated Expenses stood at $8.9 million in 2021, then grew by 24.98% to $11.1 million in 2022, then skyrocketed by 58.47% to $17.6 million in 2023, then rose by 14.67% to $20.2 million in 2024, then increased by 18.62% to $23.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for VMD at $23.9 million in Q4 2025, $25.0 million in Q3 2025, and $18.6 million in Q2 2025.